3
3
6
6
7
7
15
15
9
9
13
13
4
4
3
3
1
1
2
2
2020
2011
Company (110)University (21)
1 - 10 of 110
Sort by
Patent
Publication NumberEP 2091551 B1Filing StatusIssued PatentAvailabilityUnknownFiling Date2007-11-05Publication Date2020-01-15
Patent
Publication NumberUS 10526372Filing StatusIssued PatentAvailabilityUnknownFiling Date2018-01-02Publication Date2020-01-07
Novel compounds and methods for the inhibition of biological barrier permeability and for the inhibition of peptide translocation across biological barriers are identified. Assays for determining modulators of biological barrier permeability and for peptide translocation across biological barriers are provided. Methods for treating diseases relating to aberrant biological barrier permeability and peptide translocation across biological barriers are provided. Such diseases include celiac disea…
Patent
Publication NumberES 2700278 T3Filing StatusOtherAvailabilityUnknownFiling Date2007-02-09Publication Date2019-02-14
Enteric compositions comprising one or more tight junction agonists and/or one or more tight junction antagonists are provided. Compositions of the invention may comprise a delayed-release coating disposed over a tight junction agonist and/or tight junction antagonist layer which may be disposed over an inert core. Delayed-release coatings may be substantially stable in gastric fluid and substantially unstable in intestinal fluid, thus providing for substantial release of the tight junction a…
Patent
Publication NumberUS 20180271932Filing StatusPatent ApplicationAvailabilityUnknownFiling Date2018-03-27Publication Date2018-09-27
The present invention provides compositions comprising Larazotide. The invention further provides methods of using the Larazotide compositions for treating celiac disease in symptomatic celiac disease patients.
Patent
Publication NumberEP 2777695 B1Filing StatusIssued PatentAvailabilityUnknownFiling Date2007-02-09Publication Date2018-09-12
Patent
Publication NumberUS 20180133281Filing StatusPatent ApplicationAvailabilityUnknownFiling Date2018-01-02Publication Date2018-05-17
The present invention provides novel peptides that inhibit and/or reduce the opening of mammalian tight junctions, i.e. peptide tight junction antagonists. The present invention also provides methods for the treatment of excessive or undesirable permeability of a tissue by administering to a subject suffering from such a condition a composition comprising a peptide tight junction antagonist of the invention.
Patent
Publication NumberUS 20170096451Filing StatusPatent ApplicationAvailabilityUnknownFiling Date2016-05-20Publication Date2017-04-06
Novel compounds and methods for the inhibition of biological barrier permeability and for the inhibition of peptide translocation across biological barriers are identified. Assays for determining modulators of biological barrier permeability and for peptide translocation across biological barriers are provided. Methods for treating diseases relating to aberrant biological barrier permeability and peptide translocation across biological barriers are provided. Such diseases include celiac disea…
Patent
Publication NumberCA 2838399 CFiling StatusIssued PatentAvailabilityUnknownFiling Date2007-02-09Publication Date2017-03-07
Enteric compositions comprising one or more tight junction agonists and/or one or more tight junction antagonists are provided. Compositions of the invention may comprise a delayed- release coating disposed over a tight junction agonist and/or tight junction antagonist layer which may be disposed over an inert core. Delayed-release coatings may be substantially stable in gastric fluid and substantially unstable in intestinal fluid, thus providing for substantial release of the tight junction …
Patent
Publication NumberCN 106456549 AFiling StatusPatent ApplicationAvailabilityUnknownFiling Date2015-04-03Publication Date2017-02-22
The present invention provides compositions comprising larazotide. The invention further provides methods of using the larazotide compositions for treating celiac disease in symptomatic celiac disease patients.
Patent
Publication NumberEP 3125870 A1Filing StatusPatent ApplicationAvailabilityUnknownFiling Date2015-04-03Publication Date2017-02-08
We found 110 documents that match your Search
Research Grants: 1
Patents: 102
Clinical Trials: 6
SEC Filings: 1

Wellspring Search is the world's most comprehensive collection of enriched content about emerging and licensable technology innovations.


Already a member? Sign in